Early research (Phase 1)Study completedNCT00004862
What this trial is testing
Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Who this might be right for
Leukemia
National Cancer Institute (NCI) 24